An open-label, multicenter study in male pediatric patients with cerebral x-linked adrenoleukodystrophy (cald) to assess the effects of min-102 treatment on disease progression prior to human stem cell transplant (hsct)
|Effective start/end date||8/22/19 → 7/1/21|
- MINORYX THERAPEUTICS
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.